OrbiMed portfolio
OrbiMed (Venture capital) is known to hold 197 companies, 74 of them startups. 42 of them are hiring now, with 283 open roles. Its companies closed 19 venture rounds in 12 months, raising $1.4B. Most of them work in Drug Discovery, Oncology Therapeutics, Biologics & Biosimilars.
Companies OrbiMed has invested in
Open roles at OrbiMed portfolio companies
Focus
Co-investors
Similar investors
their companies share markets and countries
Questions about OrbiMed
How many companies has OrbiMed invested in?
OrbiMed is known to hold 197 companies: 74 startups, and 57 exits so far, read from its own portfolio page and the funding rounds that name it.
Is OrbiMed investing now?
OrbiMed has no round in the press in 12 months and no new company on its portfolio page in 90 days.
What does OrbiMed invest in?
The markets of the companies OrbiMed holds: Drug Discovery (11%), Oncology Therapeutics (7%), Biologics & Biosimilars (4%), Immunology & Inflammation Therapeutics (4%), Rare Disease Therapeutics (3%).
Which OrbiMed portfolio companies are hiring?
42 companies OrbiMed holds are hiring now, with 283 open roles listed on this page.
Who does OrbiMed invest alongside?
The investors that hold the most companies together with OrbiMed: RA Capital Management, Foresite Capital, SR One, Wellington Management, NEA.
How this page is made
A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.
Sources: its portfolio page, read Oct 25; 3 rounds in the press that name it
OrbiMed portfolio: 197 known companies. Alion, Oct 27, 2026. https://alion.io/company/orbimed/portfolio
